FDA Expands Indication for Soliqua 100/33 (insulin glargine and lixisenatide injection) to Include Type 2 Diabetes Patients Uncontrolled on Oral Antidiabetic Medicines 05/03/2019 Medications BRIDGEWATER, N.J., Feb. 27, 2019 /PRNewswire/ — The U.S. Food Read more